Breaking News Instant updates and real-time market news.

EQT

EQT Corporation

$18.69

0.68 (3.78%)

, DO

Diamond Offshore

$12.57

0.53 (4.40%)

09:55
12/07/18
12/07
09:55
12/07/18
09:55

Early notable gainers among liquid option names on December 7th

Notable gainers among liquid option names this morning include EQT Corporation (EQT) $19.28 +1.27, Diamond Offshore (DO) $12.66 +0.61, Marathon Oil (MRO) $17.05 +0.82, EOG Resources (EOG) $107.08 +4.99, and Anadarko (APC) $54.08 +2.51.

EQT

EQT Corporation

$18.69

0.68 (3.78%)

DO

Diamond Offshore

$12.57

0.53 (4.40%)

MRO

Marathon Oil

$16.83

0.61 (3.76%)

EOG

EOG Resources

$106.30

4.26 (4.17%)

APC

Anadarko

$54.19

2.62 (5.08%)

  • 13

    Dec

  • 18

    Dec

EQT EQT Corporation
$18.69

0.68 (3.78%)

11/20/18
11/20/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. LyondellBasell (LYB) upgraded to Outperform from Sector Perform at RBC Capital with analyst Arun Viswanathan saying the shares look attractive when investors "look through oil and market volatility," anticipating the company to post "robust" EBITDA growth in 2019 and 2020. 2. BP (BP) upgraded to Outperform from Market Perform at Raymond James with analyst Jean-Pierre Dmirdjian saying poor year-to-date share performance has created an attractive entry point. He also said shares screen well on free cash flow, oil leverage, and production growth. 3. CME Group (CME) upgraded to Buy from Hold at Berenberg with analyst Chris Turner saying he expects "unsettled markets" in 2019 to provide a supportive backdrop for volumes in CME's core interest rate and currency products. 4. American Vanguard (AVD) upgraded to Buy from Hold at Loop Capital with analyst Chris Kapsch saying despite "much negativity" surrounding the broader agriculture end market amid the ongoing Trump/China trade war, American Vanguard is "navigating and executing admirably." 5. EQT Corporation (EQT) upgraded to Buy from Neutral at Goldman Sachs with analyst Brian Singer saying he believes the company's production guidance calling for 5% asset sale-adjusted growth in 2019 is conservative. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/05/18
MKMP
12/05/18
INITIATION
Target $28
MKMP
Buy
EQT Corporation initiated with a Buy at MKM Partners
MKM Partners analyst John Gerdes started EQT Corporation with a Buy rating and $28 price target.
11/20/18
GSCO
11/20/18
UPGRADE
Target $23
GSCO
Buy
EQT Corporation upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Brian Singer upgraded EQT Corporation to Buy with a $23 price target. The analyst believes the company's production guidance calling for 5% asset sale-adjusted growth in 2019 is conservative. Further, he thinks concerns around management's five-year outlook are overdone. EQT's valuation is attractive following the recent underperformance of the shares, Singer tells investors in a research note.
11/20/18
GSCO
11/20/18
DOWNGRADE
Target $29
GSCO
Neutral
Cabot Oil & Gas downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Brian Singer downgraded Cabot Oil & Gas (COG) to Neutral with an unchanged price target of $29. The analyst sees less relative upside following the stock's recent outperformance driven by what he believes is a "temporary improvement" in natural gas prices. Singer believes other stocks in his coverage universe offer more attractive risk/rewards. The analyst this morning also upgraded EQT Corporation (EQT) to Buy from Neutral.
DO Diamond Offshore
$12.57

0.53 (4.40%)

11/08/18
CLKS
11/08/18
UPGRADE
CLKS
Buy
Diamond Offshore upgraded to Buy from Neutral at Clarksons Platou
11/06/18
SUSQ
11/06/18
NO CHANGE
Target $16
SUSQ
Neutral
Diamond Offshore dayrate recovery still a concern, says Susquehanna
Susquehanna analyst Charles Minervino lowered his Q4 estimates for Diamond Offshore to reflect the company's November fleet status report and incorporating his latest dayrate and cost assumptions. Minervino maintained his Neutral rating and lowered his price target to $16 from $21 on Diamond Offshore shares. He said despite his downward revisions, he remain encouraged by the company's ability to secure floating contract durations that are well above recent contract lengths.
10/18/18
FERN
10/18/18
UPGRADE
FERN
Accumulate
Diamond Offshore upgraded to Accumulate from Reduce at Fearnley
10/17/18
JRCO
10/17/18
DOWNGRADE
JRCO
Sell
Diamond Offshore downgraded to Sell from Hold at Johnson Rice
MRO Marathon Oil
$16.83

0.61 (3.76%)

12/05/18
MKMP
12/05/18
INITIATION
Target $26
MKMP
Buy
Marathon Oil initiated with a Buy at MKM Partners
MKM Partners analyst John Gerdes started Marathon Oil with a Buy rating and $26 price target.
10/19/18
MZHO
10/19/18
UPGRADE
Target $27
MZHO
Buy
Marathon Oil upgraded to Buy from Neutral at Mizuho
Mizuho analyst Paul Sankey upgraded Marathon Oil to Buy while lowering his price target for the shares to $27 from $28. The stock continues to trade at a discount to large-cap peers despite a "clear trajectory" for free cash flow growth and increasing cash return via share repurchase, Sankey tells investors in a research note. He thinks concerns about future execution in the Northern Delaware and Oklahoma are more than offset by valuation and core extension in both the Bakken and Eagle Ford.
10/23/18
WELS
10/23/18
UPGRADE
WELS
Outperform
Marathon Oil upgraded to Outperform from Market Perform at Wells Fargo
10/23/18
WELS
10/23/18
INITIATION
Target $29
WELS
Outperform
Marathon Oil assumed with an Outperform at Wells Fargo
Wells Fargo analyst Nitin Kumar assumed Marathon Oil with an Outperform rating and a price target of $29. The analyst says the management has "realigned" the company after divesting about $4.5B in non-Canadian oil sands while retaining international assets to be "farmed" for free cash flow. Kumar adds that the company also deliberately made maintained its capital budget plans unchanged, and expects it to remain "capital disciplined" while deploying free cash flow from operations and recent asset sales towards real shareholder returns.
EOG EOG Resources
$106.30

4.26 (4.17%)

12/05/18
MKMP
12/05/18
INITIATION
Target $133
MKMP
Buy
EOG Resources initiated with a Buy at MKM Partners
MKM Partners analyst John Gerdes started EOG Resources with a Buy rating and $133 price target.
12/07/18
JPMS
12/07/18
UPGRADE
Target $118
JPMS
Overweight
EOG Resources upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Arun Jayaram upgraded EOG Resources to Overweight and raised his price target for the shares to $118 from $117.
12/07/18
JPMS
12/07/18
UPGRADE
Target $118
JPMS
Overweight
JPMorgan upgrades EOG Resources to Overweight on 'more defensive tilt'
JPMorgan analyst Arun Jayaram upgraded EOG Resources (EOG) to Overweight from Neutral and raised his price target for the shares to $118 from $117. The analyst reshuffled his Large Cap Exploration & Production ratings to reflect changes in the macro environment. He likes EOG's "more defensive tilt" and expects the shares to outperform the peer group assuming oil prices remain near strip levels. Jayaram also downgraded Devon Energy (DVN) to Neutral from Overweight and Chesapeake Energy (CHK) to Underweight from Neutral.
11/16/18
FBCO
11/16/18
UPGRADE
Target $128
FBCO
Outperform
EOG Resources upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst William Featherston upgraded EOG Resources to Outperform from Neutral and maintained a $128 price target. In a research note to investors in which he calls EOG "arguably one of the best run E&P companies for a valuation near peers," Featherston says that while he acknowledges the sharp drop-off in Q4 completion activity poses a risk to 1Q19 volumes, he believes this is already well-flagged by the market with consensus forecasting 1Q19 oil production up just ~9 MBbld q/q. The analyst says shares now "finally" appear attractively priced.
APC Anadarko
$54.19

2.62 (5.08%)

11/16/18
JPMS
11/16/18
NO CHANGE
JPMS
Overweight
Anadarko strategic update a 'strong positive,' says JPMorgan
JPMorgan analyst Arun Jayaram views Anadarko Petroleum's strategic update last night for the company's 2019 capital plan and shareholder enhancement initiatives as a "strong positive." The midpoint of Anadarko's capital expenditure guidance sits 14% below the Street and only 1% below on total oil volumes, Jayaram tells investors in a research note. The company also announced a $1B increase in its buyback, 20% increase in the quarterly dividend, and $500M of incremental debt-reduction, the analyst points out. He expects the stock to trade higher today and keeps an Overweight rating on Anadarko.
11/29/18
COWN
11/29/18
INITIATION
Target $75
COWN
Outperform
Anadarko initiated with an Outperform at Cowen
Cowen started Anadarko Petroleum with an Outperform rating and $75 price target.
12/05/18
MKMP
12/05/18
INITIATION
Target $76
MKMP
Buy
Anadarko initiated with a Buy at MKM Partners
MKM Partners analyst John Gerdes started Anadarko with a Buy rating and $76 price target.
11/16/18
MUFG
11/16/18
NO CHANGE
Target $92
MUFG
Overweight
Anadarko price target lowered to $92 from $100 at MUFG
MUFG analyst Michael McAllister lowered his price target for Anadarko Petroleum to $92 after the company revealed its 2019 capital plan and production guidance. To recognize the recent action in the crude oil markets, the analyst lowered his price realization estimates by 7% for 2019 and 2020. Further, he points out that the 20% increase in his capital expenditure assumptions also has a negative effect on financial metrics. McAllister, however, reaffirms an Overweight rating on Anadarko.

TODAY'S FREE FLY STORIES

PFE

Pfizer

$42.41

0.45 (1.07%)

12:56
02/17/19
02/17
12:56
02/17/19
12:56
Hot Stocks
Pfizer, EMD Serono announce publication of Phase 3 data for BAVENCIO plus INLYTA »

Merck KGaA, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 18

    May

MRK

Merck

$79.84

0.9 (1.14%)

, PFE

Pfizer

$42.41

0.45 (1.07%)

12:48
02/17/19
02/17
12:48
02/17/19
12:48
Hot Stocks
Merck presents results from Phase 3 KEYNOTE-426 study »

Merck (MRK) announced…

MRK

Merck

$79.84

0.9 (1.14%)

PFE

Pfizer

$42.41

0.45 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 11

    Apr

  • 18

    May

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

12:42
02/17/19
02/17
12:42
02/17/19
12:42
Hot Stocks
Aveo Pharmaceuticals presents TIVO-3 trial topline results »

Aveo Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARDM

Aradigm

$0.00

(0.00%)

12:34
02/17/19
02/17
12:34
02/17/19
12:34
Hot Stocks
Aradigm announces plans for reorganization under Chapter 11 »

Aradigm has filed for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

, XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

13:26
02/16/19
02/16
13:26
02/16/19
13:26
Periodicals
Amazon a risk for almost every stock/sector, Barron's says »

Amazon (AMZN) is eating…

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

KR

Kroger

$29.50

0.54 (1.86%)

FAST

Fastenal

$62.97

0.61 (0.98%)

GWW

Grainger

$316.63

4.9 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

YETI

Yeti

$22.85

0.97 (4.43%)

13:20
02/16/19
02/16
13:20
02/16/19
13:20
Periodicals
Yeti stock has 60% upside, Barron's says »

Yeti Holdings stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

L

Loews

$46.67

0.785 (1.71%)

13:14
02/16/19
02/16
13:14
02/16/19
13:14
Periodicals
Investors can love Loews, Barron's says »

Loews is a $15B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 28

    May

EQIX

Equinix

$421.53

1.16 (0.28%)

, COR

CoreSite Realty

$102.69

0.625 (0.61%)

13:10
02/16/19
02/16
13:10
02/16/19
13:10
Periodicals
Equinix, CoreSite Realty among stocks to play data-center boom, Barron's says »

Data-center stocks may…

EQIX

Equinix

$421.53

1.16 (0.28%)

COR

CoreSite Realty

$102.69

0.625 (0.61%)

IRM

Iron Mountain

$35.13

-0.14 (-0.40%)

INXN

Interxion

$64.65

0.81 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 26

    Mar

  • 26

    Mar

NOK

Nokia

$6.31

0.015 (0.24%)

, ERIC

Ericsson

$9.36

0.015 (0.16%)

13:07
02/16/19
02/16
13:07
02/16/19
13:07
Periodicals
A U.S. ban of Huawei may benefit Ericsson, Samsung, Barron's says »

The next salvo in the…

NOK

Nokia

$6.31

0.015 (0.24%)

ERIC

Ericsson

$9.36

0.015 (0.16%)

SSNLF

Samsung

$0.00

(0.00%)

CSCO

Cisco

$49.45

1.05 (2.17%)

JNPR

Juniper

$27.12

0.16 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

COP

ConocoPhillips

$70.13

1.04 (1.51%)

, MUR

Murphy Oil

$29.23

0.59 (2.06%)

13:00
02/16/19
02/16
13:00
02/16/19
13:00
Periodicals
Dividend investors should look to oil stocks for big yields, Barron's says »

Energy stocks aren't…

COP

ConocoPhillips

$70.13

1.04 (1.51%)

MUR

Murphy Oil

$29.23

0.59 (2.06%)

CVX

Chevron

$119.30

1.19 (1.01%)

VLO

Valero

$84.34

0.75 (0.90%)

XOM

Exxon Mobil

$77.74

1.47 (1.93%)

MRO

Marathon Oil

$17.07

0.15 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 07

    Mar

  • 18

    Mar

  • 22

    May

  • 28

    May

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

12:45
02/16/19
02/16
12:45
02/16/19
12:45
Periodicals
Protestors against NY's Amazon HQ2 got math wrong, Barron's says »

On Thursday, Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

, NDAQ

Nasdaq

$87.74

0.56 (0.64%)

12:28
02/16/19
02/16
12:28
02/16/19
12:28
Periodicals
Investors interested in U.S. cannabis companies face challenges, Barron's says »

Investors interested in…

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

NDAQ

Nasdaq

$87.74

0.56 (0.64%)

CGC

Canopy Growth

$47.54

1.49 (3.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 28

    May

  • 15

    Feb

AMD

AMD

$23.68

0.55 (2.38%)

, INTC

Intel

$51.64

0.85 (1.67%)

08:43
02/16/19
02/16
08:43
02/16/19
08:43
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMD

AMD

$23.68

0.55 (2.38%)

INTC

Intel

$51.64

0.85 (1.67%)

MRVL

Marvell

$18.82

-0.37 (-1.93%)

MCHP

Microchip

$91.10

0.49 (0.54%)

MU

Micron

$41.99

-0.23 (-0.54%)

NVDA

Nvidia

$157.22

2.69 (1.74%)

QCOM

Qualcomm

$51.97

0.42 (0.81%)

TXN

Texas Instruments

$107.55

0.57 (0.53%)

TWTR

Twitter

$31.23

0.28 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 07

    Mar

  • 07

    Mar

  • 25

    Mar

  • 26

    Mar

  • 28

    May

  • 04

    Jun

  • 05

    Jun

AMGN

Amgen

$188.31

1.6 (0.86%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

04:55
02/16/19
02/16
04:55
02/16/19
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2019 ASCO Genitourinary…

AMGN

Amgen

$188.31

1.6 (0.86%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

AZN

AstraZeneca

$40.92

0.93 (2.33%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$51.64

0.81 (1.59%)

CALA

Calithera Biosciences

$5.35

0.14 (2.69%)

CLVS

Clovis

$25.44

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

ESALY

Eisai

$0.00

(0.00%)

EXEL

Exelixis

$22.26

-0.05 (-0.22%)

IMMU

Immunomedics

$14.23

0.225 (1.61%)

INO

Inovio

$3.70

0.01 (0.27%)

MRK

Merck

$79.84

0.9 (1.14%)

MYOV

Myovant Sciences

$21.48

0.1 (0.47%)

MYGN

Myriad Genetics

$31.41

0.53 (1.72%)

NH

NantHealth

$0.60

(0.00%)

NVS

Novartis

$89.89

0.865 (0.97%)

PFE

Pfizer

$42.41

0.45 (1.07%)

PGNX

Progenics

$4.87

0.13 (2.74%)

SGEN

Seattle Genetics

$71.48

2.92 (4.26%)

SNY

Sanofi

$42.51

0.94 (2.26%)

TYME

Tyme Technologies

$3.19

0.055 (1.76%)

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 16

    Feb

  • 19

    Feb

  • 20

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 11

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

WES

Western Gas Partners

$49.52

0.38 (0.77%)

, WGP

Western Gas Equity

$32.38

0.2 (0.62%)

19:30
02/15/19
02/15
19:30
02/15/19
19:30
Recommendations
Western Gas Partners, Western Gas Equity analyst commentary at MUFG »

MUFG raises price targets…

WES

Western Gas Partners

$49.52

0.38 (0.77%)

WGP

Western Gas Equity

$32.38

0.2 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 15

    Feb

  • 04

    Mar

PXD

Pioneer Natural

$145.33

2.27 (1.59%)

19:19
02/15/19
02/15
19:19
02/15/19
19:19
Recommendations
Pioneer Natural analyst commentary at MUFG »

Pioneer Natural price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

ZTS

Zoetis

$95.38

2.16 (2.32%)

18:42
02/15/19
02/15
18:42
02/15/19
18:42
Hot Stocks
Zoetis CEO says: 'Diagnostics are more important in animals than humans' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$136.40

2.13 (1.59%)

18:22
02/15/19
02/15
18:22
02/15/19
18:22
Hot Stocks
Johnson & Johnson CEO: 'We ended 2018 with great results' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

18:18
02/15/19
02/15
18:18
02/15/19
18:18
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

18:14
02/15/19
02/15
18:14
02/15/19
18:14
Hot Stocks
Biohaven treatment of multiple system atrophy granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$188.31

1.6 (0.86%)

18:11
02/15/19
02/15
18:11
02/15/19
18:11
Hot Stocks
Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$100.19

1.19 (1.20%)

18:02
02/15/19
02/15
18:02
02/15/19
18:02
Hot Stocks
Celanese announces Acetyl Intermediates price increases in China »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

17:58
02/15/19
02/15
17:58
02/15/19
17:58
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

GLD

SPDR Gold Shares

$124.81

0.77 (0.62%)

17:41
02/15/19
02/15
17:41
02/15/19
17:41
Hot Stocks
SPDR Gold Shares holdings fall to 793.03MT from 796.85MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$48.17

0.84 (1.77%)

17:26
02/15/19
02/15
17:26
02/15/19
17:26
Hot Stocks
Mondelez to transfer listing of debt securities to Nasdaq »

Mondelez International,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 06

    Mar

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.